Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Autoimmune Disease Diagnostics Market (2021-2026) by Product Type, Diagnostic Tests, Diseases, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Autoimmune Disease Diagnostics Market is estimated to be USD 4.98 Bn in 2021 and is expected to reach USD 7.84 Bn by 2026, growing at a CAGR of 9.5%.
Market Dynamics
The increasing prevalence of autoimmune diseases such as arthritis, inflammatory bowel disease, multiple sclerosis, diabetes type 1, etc. is the major factor increasing the autoimmune disease diagnostics market. The rising sedentary lifestyle leading to autoimmune diseases, growing healthcare expenditure, and increasing geriatric population have exhibited market growth.
Furthermore, government initiatives in the healthcare sector and private companies increasing investment in research and development in autoimmune diseases are anticipated to create new opportunities for the market, globally.
However, the high cost of autoimmune disease diagnostics and low awareness in emerging countries is anticipated to hamper the market growth.
Market Segmentation
- By Product Type, the market is classified into consumables & assay kits, and instruments. Amongst all, the consumables & assay kits segment is estimated to hold the highest market share during the forecast period.
- By Diagnostic Test, the market is classified as routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. Amongst the two, the routine laboratory tests segment is estimated to hold the highest market share during the forecast period.
- By Diseases, the market is classified as systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics. Amongst the two, the localized autoimmune disease diagnostics segment is estimated to hold the highest market share during the forecast period.
- By Geography, North America is projected to lead the market.
Recent Developments
- Thermo Fisher Scientific to Acquire QIAGEN N.V. a leading provider of life science and molecular diagnostic solutions having presence in around 25 countries. - 3rd March 2020.
- Progentec launched a novel blood test - aiSLET DX Flare Risk Index laboratory test that can assess the likelihood of a systemic lupus erythematosus patient experiencing an immunologic disease flare in the ensuing 12 weeks. - 15th September 2020.
Company Profiles
Some of the companies covered in this report include
- Thermo Fisher Scientific Inc
- Progentec Diagnostics, Inc
- Siemens AG
- Abbott Laboratories
- Danaher Corporation
- Bio-Rad Laboratories, Inc
- Grifols, S.A.
Key Topics Covered:
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Prevalence of Autoimmune Diseases
4.1.2 Rising Online Diagnostic Centres and Laboratory Automation
4.1.3 High Number of Research in Autoimmune Diseases
4.2 Restraints
4.2.1 Stringent Government Regulation
4.2.2 High Cost of Reimbursement
4.3 Opportunities
4.3.1 Advancement in Biosensors Diagnosis
4.3.2 Growing Healthcare Sectors in Developing Countries
4.4 Challenges
4.4.1 Lack of Awareness of Autoimmune Disease in Emerging Diseases
4.4.2 Insufficient Skilled Professional
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Autoimmune Disease Diagnostics Market, By Product Type
6.1 Introduction
6.2 Consumables & Assay Kits
6.3 Instruments
7 Global Autoimmune Disease Diagnostics Market, By Diagnostic Tests
7.1 Introduction
7.2 Routine Laboratory Tests
7.2.1 Urinalysis
7.2.2 Others
7.3 Inflammatory Markers
7.3.1 Erythrocyte Sedimentation Rate (ESR)
7.3.2 C-Reactive Protein (CRP)
7.3.3 Others
7.4 Autoantibodies And Immunologic Tests
7.4.1 Enzyme-Linked Immunosorbent Assay (ELISA)
7.4.2 Antinuclear Antibody Tests
7.4.3 Others
7.5 Other Tests
8 Global Autoimmune Disease Diagnostics Market, By Diseases
8.1 Introduction
8.2 Systemic Autoimmune Disease Diagnostics
8.2.1 Systemic Lupus Erythematosus
8.2.2 Ankylosing Spondylitis
8.2.3 Rheumatoid Arthritis
8.2.4 Others
8.3 Localized Autoimmune Disease Diagnostics
8.3.1 Inflammatory Bowel Disease
8.3.2 Type 1 Diabetes
8.3.3 Thyroid
8.3.4 Others
9 Global Autoimmune Disease Diagnostics Market, By Geography
9.1 Introduction
10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Strategic Initiatives
11 Company Profiles
- A. Menarini Diagnostics S.r.l.
- Abbott Laboratories
- AstraZeneca plc
- Beckman Coulter Inc
- Bio-Rad Laboratories, Inc
- Danaher Corporation
- Exagen Inc.
- F. Hoffmann-La Roche
- Grifols, S.A.
- Hemagen Diagnostics Inc.
- HTG Molecular Diagnostics, Inc
- Inova Diagnostics Inc.
- Novartis AG
- Pfizer Inc
- Progentec Diagnostics, Inc.
- Seramun Diagnostica GmbH
- Siemens AG
- Thermo Fisher Scientific Inc
- Trinity Biotech plc
- Werfen
For more information about this report visit https://www.researchandmarkets.com/r/hnhwzv
